(Q84862008)
Statements
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial (English)
T C Schneider
E P Corssmit
H Morreau
J W A Smit